Core Laboratories Supplemental Executive Retirement Plan for John D. Denson as Amended and Restated Effective as of January 1, 2005 Core Laboratories Supplemental Executive Retirement Plan (May 12th, 2008)
THIS SUPPLEMENTAL EXECUTIVE RETIREMENT PLAN and deferred compensation agreement is made and entered into by and between Core Laboratories N.V. (the "Company") and John D. Denson ("Executive").
Employment Agreement (Restated as of December 31, 2007) (May 12th, 2008)
Re: Convertible Senior Note Hedge Transaction Amendment (November 20th, 2006)
This letter agreement (the "Amendment") amends the terms and conditions of the Transaction (the "Transaction") entered into between Lehman Brothers OTC Derivatives Inc. ("Dealer") represented by Lehman Brothers Inc. ("Agent") as its agent, and Core Laboratories LP ("Counterparty"), pursuant to a letter agreement dated October 31, 2006 (the "Confirmation") pursuant to which Counterparty purchased from Dealer a Number of Options equal to 250,000 in connection with the issuance by Counterparty of USD 250,000,000 principal amount of 0.25% Senior Exchangeable Notes due 2011 (the "Initial Convertible Notes"). This Amendment is being entered into in connection with the issuance by Counterparty of an additional USD 50,000,000 principal amount of 0.25% Senior Exchangeable Notes due 2011 (the "Additional Convertible Notes", and together with the Initial Convertible Notes, the "Convertible Notes") to the initial purchasers of the Convertible Notes.
Core Laboratories Lp .25% Senior Exchangeable Notes Due 2011 Guaranteed by Core Laboratories N.V. Purchase Agreement (November 6th, 2006)
Core Laboratories, LP, a Delaware limited partnership (the Company), proposes to issue and sell to the initial purchasers listed on Schedule A hereto (the Initial Purchasers) for whom you are the representatives $250,000,000 principal amount of its .25% Exchangeable Notes Due 2011 (the Firm Notes) to be issued pursuant to the provisions of an Indenture to be dated as of November 6, 2006 (the Indenture) among the Company, the Guarantor (as defined below) and Wells Fargo Bank, National Association as Trustee (the Trustee). The Company also proposes to issue and sell to the Initial Purchasers not more than an additional $50,000,000 principal amount of its .25% Senior Exchangeable Notes Due 2011, solely to cover over-allotments (the Additional Notes) if and to the extent the Initial Purchasers elect to exercise the right to purchase such Additional Notes granted to the Initial Purchasers in Section 2 hereof. The Firm Notes and the Additional Notes, together with the Guarantees (as defined
First Amendment to Third Amended and Restated Credit Agreement (December 23rd, 2005)
THIS FIRST AMENDMENT TO THIRD AMENDED AND RESTATED CREDIT AGREEMENT, dated as of December 20, 2005 (the "Amendment"), among CORE LABORATORIES N.V., a Netherlands limited liability company (the "Parent"), CORE LABORATORIES, LP, a Delaware limited partnership (the "US Borrower" and collectively with the Parent, the "Borrowers"), the various financial institutions which are or may become parties to the Credit Agreement, as amended hereby (collectively, the "Lenders"), JPMORGAN CHASE BANK, N.A. as administrative agent (the "Administrative Agent") for the Lenders and as a letter of credit issuing bank (in such capacity together with any successors thereto, an "LC Issuer"), and BANK OF AMERICA, N.A. as syndication agent ("Syndication Agent" and collectively with the Administrative Agent, the "Agents") for the Lenders and as a letter of credit issuing bank (in such capacity together with any successors ther eto, an "LC Issuer").
Employment Agreement (May 23rd, 1997)